Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized magnesium sulfate in acute exacerbation of COPD
IRCT2016012420024N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD), sponsored by Tehran University of Medical Sciences. Started Jan 2016; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT2016012420024N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016012420024N3.